🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label, international, multicenter study will investigate the safe...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2014-12-01
Trial ID
NCT02187861
Treatments Being Tested
This is a randomized, open-label, multicenter, Phase 2 clinical trial desig...
Status
Terminated
Location
City of Hope
Start Date
2015-10
Trial ID
NCT02594163
Treatments Being Tested
This study aims to observe and explore the efficacy and safety of obinutuzu...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-01
Trial ID
NCT05899621
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of ofatum...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-08-26
Trial ID
NCT01077518
This open-label, randomized, phase Ib study will assess the safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00825149
Treatments Being Tested
The purpose of this study is to assess whether copanlisib in combination wi...
Status
Terminated
Location
Ironwood Physicians P.C. DBA Ironwood Cancer & Res. Ctr.
Start Date
2016-01-06
Trial ID
NCT02626455
The purpose of this study is to compare the effectiveness of bortezomib ver...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2014-11
Trial ID
NCT02424851
Treatments Being Tested
This is a study for patients with chronic lymphocytic leukemia (CLL) or sma...
Status
Active Not Recruiting
Location
Southern Cancer Center, P.C.
Start Date
2021-03-09
Trial ID
NCT04666038
Treatments Being Tested
The purpose of this Phase 2/3, randomized, multisite, open-label, dose conf...
Status
Recruiting
Location
Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)
Start Date
2022-01-14
Trial ID
NCT05139017
Follicular lymphoma (FL) is the second most common B-cell cancer and the mo...
Status
Active Not Recruiting
Location
UCSF Fresno /ID# 264712
Start Date
2024-02-05
Trial ID
NCT06191744